Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus.

Brass AL, Huang IC, Benita Y, John SP, Krishnan MN, Feeley EM, Ryan BJ, Weyer JL, van der Weyden L, Fikrig E, Adams DJ, Xavier RJ, Farzan M, Elledge SJ.

Cell. 2009 Dec 24;139(7):1243-54. doi: 10.1016/j.cell.2009.12.017.

2.

A MicroRNA Screen Identifies the Wnt Signaling Pathway as a Regulator of the Interferon Response during Flavivirus Infection.

Smith JL, Jeng S, McWeeney SK, Hirsch AJ.

J Virol. 2017 Mar 29;91(8). pii: e02388-16. doi: 10.1128/JVI.02388-16. Print 2017 Apr 15.

3.

IFITM proteins restrict antibody-dependent enhancement of dengue virus infection.

Chan YK, Huang IC, Farzan M.

PLoS One. 2012;7(3):e34508. doi: 10.1371/journal.pone.0034508. Epub 2012 Mar 30.

4.

Identification of five interferon-induced cellular proteins that inhibit west nile virus and dengue virus infections.

Jiang D, Weidner JM, Qing M, Pan XB, Guo H, Xu C, Zhang X, Birk A, Chang J, Shi PY, Block TM, Guo JT.

J Virol. 2010 Aug;84(16):8332-41. doi: 10.1128/JVI.02199-09. Epub 2010 Jun 9.

5.

Chicken interferon-inducible transmembrane protein 3 restricts influenza viruses and lyssaviruses in vitro.

Smith SE, Gibson MS, Wash RS, Ferrara F, Wright E, Temperton N, Kellam P, Fife M.

J Virol. 2013 Dec;87(23):12957-66. doi: 10.1128/JVI.01443-13. Epub 2013 Sep 25.

6.

IFITM3 inhibits influenza A virus infection by preventing cytosolic entry.

Feeley EM, Sims JS, John SP, Chin CR, Pertel T, Chen LM, Gaiha GD, Ryan BJ, Donis RO, Elledge SJ, Brass AL.

PLoS Pathog. 2011 Oct;7(10):e1002337. doi: 10.1371/journal.ppat.1002337. Epub 2011 Oct 27.

7.

[Research Progress on Antiviral Activity of Interferon-induced Transmembrane Proteins].

Chen Y, Zhu W, Shu Y.

Bing Du Xue Bao. 2016 Mar;32(2):222-8. Review. Chinese.

PMID:
27396168
8.

IFITM-Family Proteins: The Cell's First Line of Antiviral Defense.

Bailey CC, Zhong G, Huang IC, Farzan M.

Annu Rev Virol. 2014 Nov 1;1:261-283.

9.

Constitutively Expressed IFITM3 Protein in Human Endothelial Cells Poses an Early Infection Block to Human Influenza Viruses.

Sun X, Zeng H, Kumar A, Belser JA, Maines TR, Tumpey TM.

J Virol. 2016 Nov 28;90(24):11157-11167. Print 2016 Dec 15.

10.

Amphotericin B increases influenza A virus infection by preventing IFITM3-mediated restriction.

Lin TY, Chin CR, Everitt AR, Clare S, Perreira JM, Savidis G, Aker AM, John SP, Sarlah D, Carreira EM, Elledge SJ, Kellam P, Brass AL.

Cell Rep. 2013 Nov 27;5(4):895-908. doi: 10.1016/j.celrep.2013.10.033. Epub 2013 Nov 21.

11.

The IFITMs Inhibit Zika Virus Replication.

Savidis G, Perreira JM, Portmann JM, Meraner P, Guo Z, Green S, Brass AL.

Cell Rep. 2016 Jun 14;15(11):2323-30. doi: 10.1016/j.celrep.2016.05.074. Epub 2016 Jun 3.

12.

Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus.

Huang IC, Bailey CC, Weyer JL, Radoshitzky SR, Becker MM, Chiang JJ, Brass AL, Ahmed AA, Chi X, Dong L, Longobardi LE, Boltz D, Kuhn JH, Elledge SJ, Bavari S, Denison MR, Choe H, Farzan M.

PLoS Pathog. 2011 Jan 6;7(1):e1001258. doi: 10.1371/journal.ppat.1001258.

13.

The antiviral restriction factors IFITM1, 2 and 3 do not inhibit infection of human papillomavirus, cytomegalovirus and adenovirus.

Warren CJ, Griffin LM, Little AS, Huang IC, Farzan M, Pyeon D.

PLoS One. 2014 May 14;9(5):e96579. doi: 10.1371/journal.pone.0096579. eCollection 2014.

14.

Lipids and flaviviruses, present and future perspectives for the control of dengue, Zika, and West Nile viruses.

Martín-Acebes MA, Vázquez-Calvo Á, Saiz JC.

Prog Lipid Res. 2016 Oct;64:123-137. doi: 10.1016/j.plipres.2016.09.005. Epub 2016 Oct 1. Review.

PMID:
27702593
15.

IFITMs restrict the replication of multiple pathogenic viruses.

Perreira JM, Chin CR, Feeley EM, Brass AL.

J Mol Biol. 2013 Dec 13;425(24):4937-55. doi: 10.1016/j.jmb.2013.09.024. Epub 2013 Sep 25. Review.

16.

Flavivirus Infection Impairs Peroxisome Biogenesis and Early Antiviral Signaling.

You J, Hou S, Malik-Soni N, Xu Z, Kumar A, Rachubinski RA, Frappier L, Hobman TC.

J Virol. 2015 Dec;89(24):12349-61. doi: 10.1128/JVI.01365-15. Epub 2015 Sep 30.

17.

Host factors involved in West Nile virus replication.

Brinton MA.

Ann N Y Acad Sci. 2001 Dec;951:207-19. Review.

PMID:
11797778
18.

IFITM proteins restrict viral membrane hemifusion.

Li K, Markosyan RM, Zheng YM, Golfetto O, Bungart B, Li M, Ding S, He Y, Liang C, Lee JC, Gratton E, Cohen FS, Liu SL.

PLoS Pathog. 2013 Jan;9(1):e1003124. doi: 10.1371/journal.ppat.1003124. Epub 2013 Jan 24.

19.

Fatal persistence of West Nile virus subtype Kunjin in the brains of flavivirus resistant mice.

Shueb RH, Papadimitriou J, Urosevic N.

Virus Res. 2011 Feb;155(2):455-61. doi: 10.1016/j.virusres.2010.12.001. Epub 2010 Dec 15.

PMID:
21167228
20.

IFITM-2 and IFITM-3 but not IFITM-1 restrict Rift Valley fever virus.

Mudhasani R, Tran JP, Retterer C, Radoshitzky SR, Kota KP, Altamura LA, Smith JM, Packard BZ, Kuhn JH, Costantino J, Garrison AR, Schmaljohn CS, Huang IC, Farzan M, Bavari S.

J Virol. 2013 Aug;87(15):8451-64. doi: 10.1128/JVI.03382-12. Epub 2013 May 29.

Supplemental Content

Support Center